04/03/2021 Medicines for Europe Today, February 26th, Elisabeth Stampa, CEO of Medichem, has participated in the High-level launch event of the EU structured dialogue for the... read more
03/03/2021 Medicines for Europe’s press release We would like to share Medicines for Europe’s press release on the EU dialogue organized by the European Commission last 26th February t... read more
16/01/2021 New Site! Our shiny new site is now live! Check it out and discover: * Our customers' stories and how we go “beyond the pill” by providing unique benef... read more
23/12/2020 Season’s Greetings from all of us at Medichem! This year has certainly been extraordinary and we would like to express our deep gratitude for your trust. We wish you an enjoyable holiday seas... read more
24/11/2020 Medichem: added-value products with minimal environmental impact We strive to reach the United Nations Sustainable Development Goals and integrate them into our daily operations. This month, we would like to t... read more
01/11/2020 For a healthy Europe – F.A.Z. Konferenzen On October 7th, Medichem participated in the conference for a #healthyeurope to discuss how European industrial policy should strengthen API suppl... read more
16/10/2020 Introducing Sugammadex Sodium made by Medichem Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically ... read more
01/10/2020 CERTIFICATION AND MEMBERSHIPS Auditors have praised Medichem’s environmental management system after this year’s follow-up certification audit (for ISO 14001: 2015) of the pro... read more
01/09/2020 Sunitinib Malate by Medichem: manufactured in the EU, available worldwide Sunitinib malate is an oral tyrosine kinase inhibitor (TKI) used to treat renal carcinoma and gastrointestinal stromal tumors. Medichem’s Suniti... read more
07/07/2020 A Policy Roadmap for Medicines Manufacturing Leadership As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 crisis has ... read more
22/05/2020 ASIA Q1´20 – Latest Authorizations Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q1′ 20 P... read more
14/03/2020 Corporate Announcement 14.03.2020 Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care about our emplo... read more